Skip to search formSkip to main contentSkip to account menu

XIAP/cIAP1 Antagonist ASTX660

Known as: ASTX 660, ASTX660 
An orally bioavailable, non-peptidomimetic antagonist of both X chromosome-linked inhibitor of apoptosis protein (XIAP) and cellular IAP 1 (cIAP1… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: We report dose escalation results from a phase 1/2 trial of ASTX660 (NCT02503423). This non-peptidomimetic, dual XIAP… 
2018
2018
Introduction Inhibitor of Apoptosis Proteins (IAPs) are anti-apoptotic proteins which suppress the activation of caspases. IAPs… 
2017
2017
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer with a five-year survival of ~50%. HNSCC are linked… 
2016
2016
Background: Paclitaxel-mediated secretion of inflammatory mediators, including TNFα, potentially creates paracrine and autocrine… 
2015
2015
I nitially classified as potent suppressors of programed cell death, members of the inhibitor of apoptosis (IAP) family have…